Showing results (21-30 of 180) with videos related to

Sort By:
Pageof 18
European Journal of Haematology|July 19, 2008
A systematic review of phase II trials of thalidomide/dexamethasone combination therapy in patients with relapsed or refractory multiple myelomaMarie von Lilienfeld-Toal, Corinna Hahn-Ast, Kerstin Furkert, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 7, 2015
Autologous Stem Cell Transplantation Is an Effective Salvage Therapy for Primary Refractory Multiple MyelomaChristopher Parrish, Amin Rahemtulla, Jim Cavet, et al.
Leukemia|October 17, 2020
Efficacy and safety profile of deep responders to carfilzomib-based therapy: a subgroup analysis from ASPIRE and ENDEAVORKatja Weisel, Maria-Victoria Mateos, Francesca Gay, et al.
Ejhaem|February 23, 2023
What can we do about patients presenting with myeloma and severe renal failure? Observations from the UK MERIT plasma exchange trialJudith Behrens, Gill Gaskin, Neil Iggo, et al.
Plos One|June 6, 2012
Tumour cell generation of inducible regulatory T-cells in multiple myeloma is contact-dependent and antigen-presenting cell-independentSylvia Feyler, Gina B Scott, Christopher Parrish, et al.
Haematologica|March 20, 2025
Doubling in median survival in patients diagnosed with multiple myeloma 2005-2019; a real-world study from the UK's Haematological Malignancy Research NetworkAlexandra Smith, Timothy Bagguley, Eve Roman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 1, 2006
The outcome of sibling and unrelated donor allogeneic stem cell transplantation in adult patients with acute myeloid leukemia in first remission who were initially refractory to first induction chemotherapyGordon Cook, Richard E Clark, Charles Crawley, et al.
The Journal of Experimental Medicine|January 5, 2006
The fate of human Langerhans cells in hematopoietic stem cell transplantationMatthew P Collin, Derek N J Hart, Graham H Jackson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 10, 2014
Carmustine, etoposide, cytarabine, and melphalan (BEAM)-campath allogeneic stem cell transplantation for aggressive non-hodgkin lymphoma: an analysis of outcomes from the British Society of Blood and Marrow TransplantationEdward Truelove, Christopher Fox, Stephen Robinson, et al.
British Journal of Haematology|January 13, 2009
CD4(+)CD25(+)FoxP3(+) regulatory T cells are increased whilst CD3(+)CD4(-)CD8(-)alphabetaTCR(+) Double Negative T cells are decreased in the peripheral blood of patients with multiple myeloma which correlates with disease burdenSylvia Feyler, Marie von Lilienfeld-Toal, Sarah Jarmin, et al.
Pageof 18